CARBOPLATIN - THE CLINICAL-EVALUATION STRATEGY

[1] ARSENEAU JC, 1985, P AN M AM SOC CLIN, V4, P120

[2] BRAMWELL V, 1984, INVEST NEW DRUG, V2, P103

[3] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 140 - 147

[4] CALVERT AH, 1984, PLATINUM COORDINATIO, P240

[5] DEVELOPING NEW DRUGS FOR OVARIAN-CANCER - A CHALLENGING TASK IN A CHANGING REALITY [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 107 (02) : 111 - 124

[6] CREEKMORE SP, 1985, P AN M AM SOC CLIN, V4, P144

[7] CURT GA, 1983, CANCER RES, V43, P4470

[8] EVANS BD, 1985, P AM SOC CLIN ONCOL, V4, P188

[9] HORNEDOMUGUIRO J, 1985, P AN M AM SOC CLIN, V4, P136

[10] JOSS RA, 1984, INVEST NEW DRUG, V2, P297

[1] ARSENEAU JC, 1985, P AN M AM SOC CLIN, V4, P120

[2] BRAMWELL V, 1984, INVEST NEW DRUG, V2, P103

[3] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 140 - 147

[4] CALVERT AH, 1984, PLATINUM COORDINATIO, P240

[5] DEVELOPING NEW DRUGS FOR OVARIAN-CANCER - A CHALLENGING TASK IN A CHANGING REALITY [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 107 (02) : 111 - 124

[6] CREEKMORE SP, 1985, P AN M AM SOC CLIN, V4, P144

[7] CURT GA, 1983, CANCER RES, V43, P4470

[8] EVANS BD, 1985, P AM SOC CLIN ONCOL, V4, P188

[9] HORNEDOMUGUIRO J, 1985, P AN M AM SOC CLIN, V4, P136

[10] JOSS RA, 1984, INVEST NEW DRUG, V2, P297